Company Profile

KAINOS Laboratories, Inc. is pricipally engaged in researching, developing, manufacturing and selling clinical diagnostic reagents, including biochemical diagnostic reagents such as renal function related reagents and automatic biochemical analytical reagents, immune serological test reagents such as transfusion-related reagents, allergy-related reagents, cancer marker related reagents, and other reagents.

Employees

133

Sector

Medical Equipment, Supplies & Distribution

More about the company

Apr. 22	Kainos Laboratories Inc - to retire treasury shares worth 3.6% of outstanding stock on Jun 12	RE
Mar. 24	Denka Company Limited completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. from a group of shareholders.	CI
Feb. 09	Denka Company Limited proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. from a group of shareholders for ¥7.9 billion.	CI
Feb. 08	Denka Unit Launches Tender Offer for Kainos Laboratories	MT
Feb. 06	Denka Co Ltd - Will launch tender offer for Kainos shares	RE
24-12-18	Italian stationery maker FILA cuts stake in listed Indian unit DOMS	RE
22-03-13	KAINOS Laboratories, Inc. announced that it has received ¥250.47 million in funding from Sysmex Corporation	CI
22-02-24	KAINOS Laboratories, Inc. announced that it expects to receive ¥250.47 million in funding from Sysmex Corporation	CI
21-11-25	Tranche Update on KAINOS Laboratories, Inc.'s Equity Buyback Plan announced on November 25, 2021.	CI
21-11-25	KAINOS Laboratories, Inc.'s Equity Buyback announced on November 25, 2021, has closed with 150,000 shares, representing 3.66% for ¥158.1 million.	CI
21-11-25	KAINOS Laboratories, Inc. announces an Equity Buyback for 150,000 shares, for ¥158.1 million.	CI
21-11-24	KAINOS Laboratories, Inc. authorizes a Buyback Plan.	CI
20-11-25	Tranche Update on KAINOS Laboratories, Inc.'s Equity Buyback Plan announced on November 25, 2020.	CI

Current month	+0.18%
1 month	-0.22%
3 months	+0.58%
6 months	+80.72%
Current year	+78.44%

1 month	2,263	2,277
Current year	1,257	2,284
1 year	1,204	2,284
3 years	1,005	2,284
5 years	929	2,284
10 years	488	2,284

Manager	Title	Age	Since
Yukihiro Nagatsu PSD	President	67	2022-03-31
Tsukasa Hayashi ADM	Chief Administrative Officer	64	2016-05-31
Nobuaki Nakano PRN	Corporate Officer/Principal	62	2024-06-30

Director	Title	Age	Since
Yukihiro Nagatsu BRD	Director/Board Member	67	2014-05-31
Tsukasa Hayashi BRD	Director/Board Member	64	2014-05-31
Kenji Kikuchi BRD	Director/Board Member	74	2014-05-31

KAINOS Laboratories, Inc. Stock

Stocks

4556

JP3205650009

Medical Equipment, Supplies & Distribution

Chart: KAINOS Laboratories, Inc.

Latest news : KAINOS Laboratories, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: KAINOS Laboratories, Inc.

Diagnostic & Testing Substances

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KAINOS LABORATORIES, INC.	-.--%	-.--%	-	-	62.52M
GUARDANT HEALTH, INC.	+0.56%	-2.61%	+235.49%	+311.48%	20.67B
BIOMÉRIEUX	+0.41%	+4.58%	-38.34%	-21.74%	9.85B
LANTHEUS HOLDINGS, INC.	+2.36%	+1.85%	+53.31%	+18.55%	7B
10X GENOMICS, INC.	-1.66%	+2.36%	+260.00%	-25.12%	5.55B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+0.36%	+3.63%	-17.20%	-24.16%	5.23B
ANDON HEALTH CO., LTD.	+10.00%	+34.69%	+101.94%	+130.90%	4.9B
CARIS LIFE SCIENCES, INC.	+0.06%	-2.94%	-45.38%	-	4.66B
DIASORIN S.P.A.	-0.66%	+0.73%	-23.40%	-26.29%	4.2B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.66%	+4.71%	-15.83%	-39.64%	2.72B
Average	+0.88%	+5.83%	+56.73%	+40.50%	7.2B
Weighted average by Cap.	+0.99%	+3.67%	+98.20%	+108.27%